{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:15:17Z","timestamp":1728360917966},"reference-count":12,"publisher":"Aerospace Medical Association","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["aerosp med hum perform"],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:p><jats:bold>INTRODUCTION:<\/jats:bold> Israel began vaccinating with the booster dose of the Pfizer-BioNTech vaccine in July 2021, before the Food and Drug Administration (FDA) authorized the vaccine in September 2021. The first and second vaccines were shown to have several side effects that could possibly\n affect aircrews\u2019 fitness to fly. Thus, the Israel Air Force (IAF) decided on a disqualification period of 24 h following the first vaccine, and 48 h following the second vaccine. The aim of this study was to determine the disqualification period following the booster dose of the vaccine.<jats:bold>METHODS:<\/jats:bold>\n A survey was conducted among IAF aviators in the Aeromedical Center (AMC) in order to characterize the side effects and their duration following a Pfizer-BioNTech COVID-19 vaccine booster dose.<jats:bold>RESULTS:<\/jats:bold> The most common local side effect was injection site pain. The most common systemic\n side effects were general weakness, fatigue, and myalgia. Duration of side effects was up to 48 h from vaccine administration among the majority of aircrew members.<jats:bold>CONCLUSION:<\/jats:bold> The IAF AMC policy for the Pfizer-BioNTech COVID-19 vaccine booster dose recipients is to disqualify from\n flight for 48 h following the vaccination.<jats:bold>Ekshtein A, Hay G, Shapira S, Ben-Ari O. <jats:italic>Return to flying duties following a COVID-19 booster dose<\/jats:italic>. Aerosp Med Hum Perform. 2022; 93(7):593\u2013596.<\/jats:bold><\/jats:p>","DOI":"10.3357\/amhp.6044.2022","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T04:32:30Z","timestamp":1658377950000},"page":"593-596","source":"Crossref","is-referenced-by-count":0,"title":["Return to Flying Duties Following a COVID-19 Booster Dose"],"prefix":"10.3357","volume":"93","author":[{"given":"Aya","family":"Ekshtein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shachar","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oded","family":"Ben-Ari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1911","reference":[{"year":"2020","key":"B1","article-title":"Briefing document: Pfizer-BioNTech COVID-19 vaccine. Vaccines and Related Biological Products Advisory Committee Meeting"},{"issue":"9","key":"B2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3357\/AMHP.5882.2021","article-title":"COVID-19 vaccine and fitness to fly","volume":"92","author":"Gabbai","year":"2021","journal-title":"Aerosp Med Hum Perform."},{"issue":"8","key":"B3","first-page":"283","article-title":"First month of COVID-19 vaccine safety monitoring - United States","volume":"70","author":"Gee","year":"2021"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1101\/2021.08.24.21262423","article-title":"Waning immunity of the BNT162b2 vaccine: a nationwide study from Israel","author":"Goldberg","year":"2021"},{"key":"B5"},{"key":"B6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"year":"2021","author":"Mizrahi","key":"B7"},{"year":"2020","key":"B8"},{"issue":"7","key":"B9","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad","year":"2021","journal-title":"J Clin Med."},{"year":"2020","author":"Ritchie","key":"B10"},{"key":"B11","first-page":"6","article-title":"Israel\u2019s rapid rollout of vaccinations for COVID-19","volume":"10","author":"Rosen","year":"2021"},{"issue":"10292","key":"B12","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(21)01290-3","article-title":"Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination","volume":"397","author":"Wall","year":"2021","journal-title":"Lancet."}],"container-title":["Aerospace Medicine and Human Performance"],"original-title":[],"link":[{"URL":"https:\/\/asma.kglmeridian.com\/view\/journals\/amhp\/93\/7\/article-p593.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/asma.kglmeridian.com\/downloadpdf\/journals\/amhp\/93\/7\/article-p593.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/asma.kglmeridian.com\/downloadpdf\/journals\/amhp\/93\/7\/article-p593.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:33:05Z","timestamp":1728304385000},"score":1,"resource":{"primary":{"URL":"https:\/\/asma.kglmeridian.com\/view\/journals\/amhp\/93\/7\/article-p593.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":12,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.3357\/amhp.6044.2022","relation":{},"ISSN":["2375-6314","2375-6322"],"issn-type":[{"type":"print","value":"2375-6314"},{"type":"electronic","value":"2375-6322"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}